blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0303471

EP0303471 - C.12 modified erythromycin A derivatives [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.09.1992
Database last updated on 03.06.2024
Most recent event   Tooltip10.09.1992No opposition filed within time limitpublished on 28.10.1992 [1992/44]
Applicant(s)For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
[N/P]
Former [1989/07]For all designated states
PFIZER INC.
235 East 42nd Street
New York, N.Y. 10017 / US
Inventor(s)01 / Hauske, James R., Dr.
15, Westchester Drive
East Lyme Connecticut 06333 / US
[1989/07]
Representative(s)Bradbrook, Geoffrey William, et al
PFIZER LIMITED Ramsgate Road Sandwich
Kent, CT13 9NJ / GB
[N/P]
Former [1989/07]Bradbrook, Geoffrey William, et al
PFIZER LIMITED Ramsgate Road
Sandwich Kent, CT13 9NJ / GB
Application number, filing date88307407.210.08.1988
[1989/07]
Priority number, dateUS1987008544614.08.1987         Original published format: US 85446
[1989/07]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0303471
Date:15.02.1989
Language:EN
[1989/07]
Type: A3 Search report 
No.:EP0303471
Date:25.10.1989
Language:EN
[1989/43]
Type: B1 Patent specification 
No.:EP0303471
Date:06.11.1991
Language:EN
[1991/45]
Search report(s)(Supplementary) European search report - dispatched on:EP07.09.1989
ClassificationIPC:C07H17/08, A61K31/70
[1989/07]
CPC:
C07H17/08 (EP,US); A61P31/04 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1989/07]
TitleGerman:Erythromycin-A-Derivate, modifiziert in Position-C-12[1989/07]
English:C.12 modified erythromycin A derivatives[1989/07]
French:Dérivés de l'érythromycine A modifiés en position C-12[1989/07]
Examination procedure19.08.1988Examination requested  [1989/07]
03.04.1991Despatch of communication of intention to grant (Approval: Yes)
02.05.1991Communication of intention to grant the patent
22.06.1991Fee for grant paid
22.06.1991Fee for publishing/printing paid
Opposition(s)07.08.1992No opposition filed within time limit [1992/44]
Fees paidRenewal fee
27.06.1990Renewal fee patent year 03
02.07.1991Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]  - THE JOURNAL OF ORGANIC CHEMISTRY, vol. 48, no. 25, 16th December 1983, pages 5138-5140, American Chemical Society; J.R. HAUSKE et al.: "Aglycon modifications of erythromycin A and erythromycin B: Regiospecific nucleophilic ring opening of cyclic thionocarbonates"
 [XP]  - THE JOURNAL OF ORGANIC CHEMISTRY, vol. 52, no. 20, 2nd October 1987, pages 4622-4625, American Chemical Society; J.R. HAUSKE et al.: "Algycon modifications of erythromycin A: Regiospecific and stereospecific elaboration of the C-12 position"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.